S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)

Cellebrite DI (CLBT) SEC Filings & 10K Form

$11.92
+0.21 (+1.79%)
(As of 10:34 AM ET)

Recent Cellebrite DI SEC Filings

DateFilerForm TypeView
02/23/2024
5:02 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
3:21 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:23 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Utsumi Ryusuke (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
6:15 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/08/2024
4:14 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SAFERWORLD, LIMITED PARTNERSHIP (Filed by)
Form SC 13G/A
02/08/2024
3:10 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/08/2024
8:07 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
SUNCORPORATION (Filed by)
Form SC 13G/A
01/11/2024
6:14 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
5:35 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
6:51 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
3:31 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
SHANI HAIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
6:57 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
3:19 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
10:20 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
6:55 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:30 PM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
5:38 AM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
3:15 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
4:57 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
3:21 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:20 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:20 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:22 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:12 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
3:49 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
6:39 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
6:20 PM
Basore Ken (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:33 PM
Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:33 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:36 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:13 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Veinstein Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:17 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2023
3:46 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
3:40 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
3:50 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
3:25 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
3:18 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:11 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:14 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
3:51 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
3:24 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
4:03 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:26 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
3:25 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
4:16 PM
Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:53 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
4:32 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Veinstein Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
6:05 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2023
6:10 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
3:16 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/21/2023
3:05 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
3:09 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
3:01 PM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
3:35 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
4:01 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
3:23 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
4:05 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
3:07 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
3:08 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
3:19 PM
Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
3:21 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
4:10 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2023
4:39 PM
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
6:40 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2023
6:13 AM
Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CLBT) was last updated on 2/26/2024 by MarketBeat.com Staff